Molecules/BREXUCABTAGENE AUTOLEUCEL

BREXUCABTAGENE AUTOLEUCEL

CHEMBL4594618

Compare

Molecular Identity

BREXUCABTAGENE AUTOLEUCEL

ChEMBL ID: CHEMBL4594618

GeneApprovedFirst approved 2020

Mechanism of action: B-lymphocyte antigen CD19 binding agent

Properties

Molecular Formula

0.00

Molecular Weight

g/mol

Synonyms(4)

AUTOLOGOUS PERIPHERAL BLOOD T CELLS CD4 AND CD8 SELECTED AND CD3 AND CD28 ACTIVATED TRANSDUCED WITH RETROVIRAL VECTOR EXPRESSING ANTI-CD19 CD28/CD3-ZETA CHIMERIC ANTIGEN RECEPTOR AND CULTURED (BREXUCABTAGENE AUTOLEUCEL)BREXUCABTAGENE AUTOLEUCELKTE-X19TECARTUS

Data from ChEMBL (EMBL-EBI)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Drug Network

Trials and conditions connected to BREXUCABTAGENE AUTOLEUCEL

Loading drug network...